BioMarin Pharmaceutical Inc. (BMRN) Risk Reward Looks Very Attractive Ahead of Voxzogo Launch - BofA Securities
Tweet Send to a Friend
BofA Securities analyst Geoff Meacham reiterated a Buy rating and $110.00 price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ahead ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
